Replies to post #181048 on Biotech Values

[Double_Bagel]

So basically your complaint is that a person whose job it is to write about biotech published an opinion that caused your stock to crash. Quite rude.

It would be much more thoughtful if in the future he first consulted with you about your portfolio before publishing.

Come on Old! That is not what I said. He has been so wrong on this and he is not admitting this -- that is what I was talking about.

Yes, it did hurt me then. But I am laughing now :-)

The Aug $12.5 calls at 0.25 are looking good. So are the Aug $15 calls at 0.5 and the Sep $15 calls at 0.9

TKMR, CLVS and SRPT and ARWR are doing good today. Heck, even MNTA is up :-)

Now ENTA is a different matter. I just might have to buy more here.